Ricerca Biosciences Releases Foresight Similarity Analysis Service

Article

Company News Release

Ricerca Biosciences

, a preclinical contract research organization providing services to the biopharmaceutical industry, has announced its similarity analysis service, Foresight™.  

Foresight allows compound assay results to be compared against the assay results of a large reference set of pharmacologically active compounds. The tool helps predict

in vivo

effects from

in vitro

pharmacology data and provides insight into additional, non-obvious compound activities.

The analysis service allows scientists to discover clues to the possibilities of a compound. Foresight can be used to direct compound modification to avoid adverse effects and determine new indications for safe or novel compounds.

Ricerca has previous worked with clients to profile compounds in the discovery space. With the development of this tool, Ricerca can now offer interpretation and predictive analysis of pharmacological data.

Related Videos
Greg Ball, Founder, ASAP Process Consulting image credit screen shot from video
Janice Chang, CEO, TransCelerate BioPharma @ video screenshot.
Applied Clinical Trials and LabConnect
Related Content
© 2024 MJH Life Sciences

All rights reserved.